Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Recent patents claim novel therapeutic agents for ocular disorders

May 3, 2006

Pre-NDA meeting for AzaSite

May 3, 2006

Genaera updates findings from phase II trials of Evizon

May 2, 2006

Alcon and Amgen collaborate on therapeutics for eye diseases

April 26, 2006

Pathogenics licenses N-chlorotaurine rights to Acuity

April 25, 2006

End of phase II testing of diquafosol in Asia triggers milestone payment

April 24, 2006

Major component of green tea may be useful in ocular diseases

April 19, 2006

Vaccination with PN-277 may be useful in preventing retinal neurodegeneration

April 18, 2006

Series C financing at Novagali Pharma

April 18, 2006

Preclinical and clinical studies examine ocular effects of bevacizumab

April 11, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...